CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

Clinical trial NCT05054257 · RECRUITING

Trial details

NCT number: NCT05054257
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma Refractory Non-Hodgkin's Lymphoma, Relapsed

Start date: 2021-06-02
Primary completion: 2025-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.